Clinical Trials Directory

Trials / Sponsors / Emalex Biosciences Inc.

Emalex Biosciences Inc.

Industry · 17 registered clinical trials.

StatusTrialPhaseStarted
CompletedFood-effect Study of Ecopipam Pharmacokinetics
Food-effect
Phase 12024-11-05
CompletedDrug Interaction Study
Drug Interaction
Phase 12024-01-18
Active Not RecruitingA Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's D
Tourette Syndrome
Phase 32023-08-16
CompletedThorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
QT/QTc
Phase 12023-03-15
CompletedEcopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Tourette Disorder
Phase 32023-01-31
CompletedDrug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Drug Interaction
Phase 12022-04-26
CompletedDrug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active
Drug Interaction
Phase 12021-05-13
CompletedStudy of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects
Healthy Volunteer
Phase 12021-05-12
TerminatedDrug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Drug-Interactions
Phase 12021-02-18
CompletedEffects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Childhood-Onset Fluency Disorder (Stuttering)
Phase 22020-10-02
CompletedEcopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
Tourette Syndrome in Children, Tourette Syndrome in Adolescence
Phase 22019-10-04
CompletedEcopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
Tourette Syndrome
Phase 22019-06-28
CompletedEcopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years
Tourette's Syndrome
Phase 22014-03-01
TerminatedEcopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Lesch-Nyhan Disease, Self-injurious Behavior
Phase 32012-12-01
CompletedSafety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam
Healthy
Phase 12011-08-01
CompletedClinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
Pathological Gambling
Phase 22010-10-01
AvailableExpanded Access Program for Treatment With Ecopipam for Tourette's Disorder
Tourettes Disorder, Tourette Disorder
——